CD20 articles & resources on Made-in-China.com

European Commission Approve Roche's MabThera 1400mg Solution for SC Injection

Feb 7, 2014

The EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Roche's MabThera (rituximab) 1400mg solution for subcutaneous (SC) injection for the treatment of patients with common forms ...

Tags: CHMP, NHL, SC, CD20

FDA Approved Roche's Drug Gazyva in Combination with Chlorambucil Chemotherapy

Nov 5, 2013

The US Food and Drug Administration (FDA) has approved Roche's new drug Gazyva (obinutuzumab) in combination with chlorambucil chemotherapy for treatment of patients with chronic lymphocytic leukemia (CLL) who have not previously been ...

Tags: Combination Vaccine, Medicine

Dendritic-Cell Vaccine Technology for Lymphomas and Leukemias Created with Immunomedics

Oct 24, 2013

US-based biopharmaceutical company Immunomedics has announced the issuance of a US patent to its majority-owned subsidiary, IBC Pharmaceuticals, for ‘Novel Strategies for Improved Cancer Vaccines’. The new patent concerns ...

Tags: Lymphomas, Leukemias

GSK and Danish Biotechnology Firm Genmab Have Filed a Supplemental Agreement

Oct 22, 2013

GlaxoSmithKline (GSK) and Danish biotechnology firm Genmab have filed a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) for the use of its leukaemia drug Arzerra (ofatumumab) in combination ...

Tags: GlaxoSmithKline, CLL Patients

The FDA Has Approved Breakthrough Therapy Designation for Genmab and Arzerra

Sep 17, 2013

The US Food and Drug Administration (FDA) has approved breakthrough therapy designation for Danish biotechnology company Genmab and British pharmaceutical company GlaxoSmithKline’s (GSK) Arzerra (ofatumumab) in combination with ...

Tags: therapy designation, Medicine

TG Therapeutics and Ildong Pharmaceutical to Develop and Commercialize Ublituximab

Nov 29, 2012

TG Therapeutics and Ildong Pharmaceutical have signed a licensing deal to develop and commercialize an oncology candidate, Ublituximab, in South Korea and Southeast Asia. Under the contract, Ildong gains Ublituximab development rights in ...

Tags: TG, Ildong Pharmaceutical, Ublituximab

Genmab Announced GSK Entered Into a Patent Settlement Agreement with Genentech

Mar 27, 2012

Genmab has announced that GlaxoSmithKline (GSK) entered into a patent settlement agreement with Genentech and City of Hope for Ofatumumab. GSK is Genmab's development and commercial collaborator for the CD20 antibody of atumumab. ...

Tags: patent, patent settlement agreement, ofatumumab